As of 9:42am ET
| +0.01 / +0.07%|
The 7 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 22.40, with a high estimate of 23.59 and a low estimate of 17.20. The median estimate represents a +58.84% increase from the last price of 14.10.
The current consensus among 7 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.